Atefeh Razazan

811 total citations
21 papers, 649 citations indexed

About

Atefeh Razazan is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Atefeh Razazan has authored 21 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Atefeh Razazan's work include Immunotherapy and Immune Responses (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and RNA Interference and Gene Delivery (6 papers). Atefeh Razazan is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and RNA Interference and Gene Delivery (6 papers). Atefeh Razazan collaborates with scholars based in Iran, United States and Canada. Atefeh Razazan's co-authors include Javad Behravan, Sidharth P. Mishra, Shalini Jain, Hariom Yadav, Shaohua Wang, Ravinder Nagpal, Shokouh Ahmadi, Nastaran Barati, Mahmoud Reza Jaafari and Atefeh Arab and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Atefeh Razazan

19 papers receiving 639 citations

Peers

Atefeh Razazan
Atefeh Razazan
Citations per year, relative to Atefeh Razazan Atefeh Razazan (= 1×) peers Marcela Esquivel‐Velázquez

Countries citing papers authored by Atefeh Razazan

Since Specialization
Citations

This map shows the geographic impact of Atefeh Razazan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atefeh Razazan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atefeh Razazan more than expected).

Fields of papers citing papers by Atefeh Razazan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atefeh Razazan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atefeh Razazan. The network helps show where Atefeh Razazan may publish in the future.

Co-authorship network of co-authors of Atefeh Razazan

This figure shows the co-authorship network connecting the top 25 collaborators of Atefeh Razazan. A scholar is included among the top collaborators of Atefeh Razazan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atefeh Razazan. Atefeh Razazan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Razazan, Atefeh, William T. Goldsmith, Anand Ranpara, et al.. (2025). Ozone Generation Method Impacts Lung Toxicity and Oxidant Signaling. American Journal of Respiratory Cell and Molecular Biology. 74(1). 18–26.
2.
Deng, Wentao, et al.. (2023). Head-to-Head Comparison of CCN4, DNMT3A, PTPN11, and SPARC as Suppressors of Anti-tumor Immunity. Cellular and Molecular Bioengineering. 16(5-6). 431–442. 2 indexed citations
3.
Klinke, David J., et al.. (2022). Data-driven learning how oncogenic gene expression locally alters heterocellular networks. Nature Communications. 13(1). 1986–1986. 4 indexed citations
4.
Fernández, Audry, Wentao Deng, Sarah L. McLaughlin, et al.. (2022). Cell Communication Network factor 4 promotes tumor‐induced immunosuppression in melanoma. EMBO Reports. 23(4). e54127–e54127. 11 indexed citations
5.
Razazan, Atefeh, Prashantha Karunakar, Sidharth P. Mishra, et al.. (2021). Activation of Microbiota Sensing – Free Fatty Acid Receptor 2 Signaling Ameliorates Amyloid-β Induced Neurotoxicity by Modulating Proteolysis-Senescence Axis. Frontiers in Aging Neuroscience. 13. 735933–735933. 21 indexed citations
6.
Barati, Nastaran, Amin Reza Nikpoor, Fatemeh Mosaffa, et al.. (2021). AE36 HER2/neu-derived peptide linked to positively charged liposomes with CpG-ODN as an effective therapeutic and prophylactic vaccine for breast cancer. Journal of Drug Delivery Science and Technology. 67. 102904–102904. 7 indexed citations
7.
Momtazi‐Borojeni, Amir Abbas, Atefeh Razazan, Mercedeh Mansourian, et al.. (2020). Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer. PLoS ONE. 15(12). e0243550–e0243550. 15 indexed citations
8.
Ahmadi, Shokouh, Shaohua Wang, Ravinder Nagpal, et al.. (2020). A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota/taurine/tight junction axis. JCI Insight. 5(9). 197 indexed citations
9.
Razazan, Atefeh, Prashantha Karunakar, Sidharth P. Mishra, Shailesh Sharma, & Hariom Yadav. (2020). Fenchol ameliorates Alzheimer’s disease like phenotypes by modulating microbiome/proteolysis/senescence axis. Alzheimer s & Dementia. 16(S9).
10.
Ahmadi, Shokouh, Atefeh Razazan, Ravinder Nagpal, et al.. (2020). Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis. The Journals of Gerontology Series A. 75(7). e9–e21. 124 indexed citations
11.
Barati, Nastaran, Amir Abbas Momtazi‐Borojeni, Atefeh Arab, et al.. (2019). P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer. Artificial Cells Nanomedicine and Biotechnology. 47(1). 664–672. 29 indexed citations
12.
Razazan, Atefeh, Roderick Slavcev, Nastaran Barati, et al.. (2019). Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice. Scientific Reports. 9(1). 2221–2221. 31 indexed citations
13.
Razazan, Atefeh & Javad Behravan. (2019). Single peptides and combination modalities for triple negative breast cancer. Journal of Cellular Physiology. 235(5). 4089–4108. 9 indexed citations
14.
Behravan, Javad, et al.. (2019). Towards Breast Cancer Vaccines, Progress and Challenges. Current Drug Discovery Technologies. 16(3). 251–258. 25 indexed citations
15.
Barati, Nastaran, Atefeh Razazan, Roderick Slavcev, et al.. (2018). Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice. Cancer Letters. 424. 109–116. 26 indexed citations
16.
Arab, Atefeh, Javad Behravan, Atefeh Razazan, et al.. (2017). A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice. Journal of drug targeting. 26(4). 365–372. 38 indexed citations
17.
Razazan, Atefeh, Javad Behravan, Atefeh Arab, et al.. (2017). Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS ONE. 12(10). e0185099–e0185099. 46 indexed citations
18.
Arab, Atefeh, Roderick Slavcev, Atefeh Razazan, et al.. (2017). Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response. Immunologic Research. 66(1). 200–206. 28 indexed citations
19.
Barati, Nastaran, Amin Reza Nikpoor, Atefeh Razazan, et al.. (2017). Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer. Immunology Letters. 190. 108–117. 24 indexed citations
20.
Mohammadpour, Raziye, Shahrokh Safarian, Nader Sheibani, Saeed Norouzi, & Atefeh Razazan. (2013). Death inducing and cytoprotective autophagy in T‐47D cells by two common antibacterial drugs: sulphathiazole and sulphacetamide. Cell Biology International. 37(4). 348–358. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026